ArticleThe Journal of infectious diseases2022
Changing Epidemiology of Varicella Outbreaks in the United States During the Varicella Vaccination Program, 1995-2019.
Article in The Journal of infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- A Cross-Sectional Seroepidemiological Study on Varicella Zoster Virus in Zhejiang, China.Vaccines · 2026Article
- Atypical High-Burden Breakthrough Varicella: A Diagnostic Pitfall in the Two-Dose Vaccine Era.Cureus · 2026Article
- A fresh look at varicella vaccination.Human vaccines & immunotherapeutics · 2025Review
- Risk assessment of communicable respiratory diseases transmission based on social contact networks: a primary school contact data survey conducted with portable high-precision devices.BMC public health · 2025Article
- Epidemiologic Investigation of a Varicella Outbreak in an Elementary School in Gyeonggi Province, Republic of Korea.Children (Basel, Switzerland) · 2025Article
- Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017-2022): a registry-based case-cohort study.BMC public health · 2025Article
- The impact of social vulnerability on primary vaccine coverage in children with sickle cell disease.Frontiers in public health · 2025Article
- Seroprevalence Assessment of Anti-Varicella Antibodies among Adults in the Province of Florence (Italy).Vaccines · 2024Article
- Review
- Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study.Human vaccines & immunotherapeutics · 2023Observational
- Epidemiological Characteristics of Varicella Outbreaks - China, 2006-2022.China CDC weekly · 2023Article
- An Autoregressive Integrated Moving Average Model for Predicting Varicella Outbreaks - China, 2019.China CDC weekly · 2023Article
- 25 Years of Varicella Vaccination in the United States.The Journal of infectious diseases · 2022Article
- Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone.The Journal of infectious diseases · 2022Article
- Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020.The Journal of infectious diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We describe the changing epidemiology of varicella outbreaks informed by past and current active and passive surveillance in the United States by reviewing data published during 1995-2015 and analyzing new data from 2016 to 2019. Varicella outbreaks were defined as ≥5 varicella cases within 1 setting and ≥1 incubation period. During the 1-dose varicella vaccination program (1995‒2006), the number of varicella outbreaks declined by 80% (2003-2006 vs 1995-1998) in 1 active surveillance area where vaccination coverage reached 90.5% in 2006. During the 2-dose program, in 7 states with consistent reporting to the Centers for Disease Control and Prevention, the number of outbreaks declined by 82% (2016-2019 vs 2005-2006). Over the entire program (1995-2019), outbreak size and duration declined from a median of 15 cases/outbreak and 45 days duration to 7 cases and 30 days duration. The proportion of outbreaks with <10 cases increased from 28% to 73%. During 2016‒2019, most (79%) outbreak cases occurred among unvaccinated or partially vaccinated persons eligible for second-dose vaccination, highlighting the potential for further varicella control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.